This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Benjamin Blaha
Co-CEO / CTO at Fuse Vectors
Speaker

Profile

Benjamin Blaha is the technical co-founder and co-CEO of Fuse Vectors, developing disruptive vector technologies to power the next generation of advanced therapies. He holds a PhD in Biochemical Engineering from University College London and has led process development and CMC functions at leading biotech companies across Europe and the US, including UniQure, ImmuneBridge, and the UK’s Cell and Gene Therapy Catapult. His work has focused on translating scientific innovation into scalable manufacturing, building high-performing teams, and advancing the delivery of transformative therapies to patients worldwide.

Agenda Sessions

  • Merck's EMEA Advance Biotech Grant at BIO-Europe

    16:00